Skip to main content
Top
Published in: Diabetologia 9/2018

01-09-2018 | Article

Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes

Authors: Raija Lithovius, Daniel Gordin, Carol Forsblom, Markku Saraheimo, Valma Harjutsalo, Per-Henrik Groop, on behalf of the FinnDiane Study Group

Published in: Diabetologia | Issue 9/2018

Login to get access

Abstract

Aims/hypothesis

This study aimed to assess the use of ambulatory BP monitoring (ABPM) to identify the presence of masked, nocturnal and white-coat hypertension in individuals with type 1 diabetes, patterns that could not be detected by regular office-based BP monitoring alone. We also analysed associations between BP patterns and arterial stiffness in order to identify individuals at cardiovascular risk.

Methods

This substudy included 140 individuals with type 1 diabetes from the Helsinki metropolitan area, who attended the Finnish Diabetic Nephropathy Study (FinnDiane) Centre in Helsinki between January 2013 and August 2017. Twenty-four hour ABPM and pulse wave analysis were performed simultaneously using a validated non-invasive brachial oscillometric device (Mobil-O-Graph). Definitions of hypertension were based on the European Society of Hypertension guidelines. Masked hypertension was defined as normal office BP (BP obtained using a standardised automated BP device) but elevated 24 h ABPM, and white-coat hypertension as elevated office BP but normal 24 h ABPM.

Results

A total of 38% of individuals were normotensive and 33% had sustained hypertension, while 23% had masked and 6% had white-coat hypertension. About half of the cohort had increased absolute levels of night-time BP, half of whom were untreated. In the ambulatory setting, central BP and pulse wave velocity (PWV) were higher in participants with masked hypertension than in those with normotension (p ≤ 0.001). In a multivariable linear regression model adjusted for age, sex, BMI, antihypertensive treatment and eGFR, masked hypertension was independently associated with higher 24 h PWV (β 0.50 [95% CI 0.34, 0.66]), but not with PWV obtained during resting conditions (adjusted β 0.28 [95% CI −0.53, 1.10]), using normotension as the reference group.

Conclusions/interpretation

ABPM analysis revealed that one-quarter of the participants with type 1 diabetes had masked hypertension; these individuals would not have been detected by office BP alone. Moreover, arterial stiffness was increased in individuals with masked hypertension. These findings support the use of ABPM to identify individuals at risk of cardiovascular disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144–148CrossRefPubMed Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144–148CrossRefPubMed
2.
go back to reference Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ (2000) Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159–169CrossRefPubMed Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ (2000) Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159–169CrossRefPubMed
3.
go back to reference Lithovius R, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH, on behalf of the FinnDiane Study Group (2014) Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy. Diabetes Care 37:709–717CrossRefPubMed Lithovius R, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH, on behalf of the FinnDiane Study Group (2014) Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy. Diabetes Care 37:709–717CrossRefPubMed
4.
go back to reference Mancia G, Verdecchia P (2015) Clinical value of ambulatory blood pressure: evidence and limits. Circ Res 116:1034–1045CrossRefPubMed Mancia G, Verdecchia P (2015) Clinical value of ambulatory blood pressure: evidence and limits. Circ Res 116:1034–1045CrossRefPubMed
5.
go back to reference Solak Y, Kario K, Covic A et al (2016) Clinical value of ambulatory blood pressure: is it time to recommend for all patients with hypertension? Clin Exp Nephrol 20:14–22CrossRefPubMed Solak Y, Kario K, Covic A et al (2016) Clinical value of ambulatory blood pressure: is it time to recommend for all patients with hypertension? Clin Exp Nephrol 20:14–22CrossRefPubMed
6.
go back to reference Hodgkinson J, Mant J, Martin U et al (2011) Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 342:d3621CrossRefPubMedPubMedCentral Hodgkinson J, Mant J, Martin U et al (2011) Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 342:d3621CrossRefPubMedPubMedCentral
7.
go back to reference Lazaridis AA, Sarafidis PA, Ruilope LM (2015) Ambulatory blood pressure monitoring in the diagnosis, prognosis, and management of resistant hypertension: still a matter of our resistance? Curr Hypertens Rep 17:78CrossRefPubMed Lazaridis AA, Sarafidis PA, Ruilope LM (2015) Ambulatory blood pressure monitoring in the diagnosis, prognosis, and management of resistant hypertension: still a matter of our resistance? Curr Hypertens Rep 17:78CrossRefPubMed
8.
go back to reference Pickering TG, Davidson K, Gerin W, Schwartz JE (2002) Masked hypertension. Hypertension 40:795–796CrossRefPubMed Pickering TG, Davidson K, Gerin W, Schwartz JE (2002) Masked hypertension. Hypertension 40:795–796CrossRefPubMed
9.
go back to reference O’Brien E, Parati G, Stergiou G et al (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31:1731–1768CrossRefPubMed O’Brien E, Parati G, Stergiou G et al (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31:1731–1768CrossRefPubMed
10.
go back to reference Franklin SS, Thijs L, Li Y et al (2013) Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 61:964–971CrossRefPubMedPubMedCentral Franklin SS, Thijs L, Li Y et al (2013) Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 61:964–971CrossRefPubMedPubMedCentral
11.
go back to reference George B, Bantwal G, Ayyar V, Mathew V (2015) Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls. J Diabetes Sci Technol 9:138–144CrossRefPubMed George B, Bantwal G, Ayyar V, Mathew V (2015) Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls. J Diabetes Sci Technol 9:138–144CrossRefPubMed
12.
go back to reference Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013) Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 36:715–721CrossRefPubMedPubMedCentral Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013) Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 36:715–721CrossRefPubMedPubMedCentral
13.
go back to reference Nilsson PM, Lurbe E, Laurent S (2008) The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 26:1049–1057CrossRefPubMed Nilsson PM, Lurbe E, Laurent S (2008) The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 26:1049–1057CrossRefPubMed
14.
go back to reference Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH, Finnish Diabetic Nephropathy (FinnDiane) Study Group (2004) Altered age-related blood pressure pattern in type 1 diabetes. Circulation 110:1076–1082CrossRefPubMed Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH, Finnish Diabetic Nephropathy (FinnDiane) Study Group (2004) Altered age-related blood pressure pattern in type 1 diabetes. Circulation 110:1076–1082CrossRefPubMed
15.
go back to reference Gordin D, Waden J, Forsblom C et al (2011) Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (the FinnDiane study). Diabetes Care 34:886–891CrossRefPubMedPubMedCentral Gordin D, Waden J, Forsblom C et al (2011) Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (the FinnDiane study). Diabetes Care 34:886–891CrossRefPubMedPubMedCentral
16.
go back to reference Takeno K, Mita T, Nakayama S et al (2012) Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens 25:165–170CrossRefPubMed Takeno K, Mita T, Nakayama S et al (2012) Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens 25:165–170CrossRefPubMed
17.
go back to reference Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J (2016) Twenty-four-hour ambulatory pulse wave analysis in hypertension management: current evidence and perspectives. Curr Hypertens Rep 18:72CrossRefPubMed Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J (2016) Twenty-four-hour ambulatory pulse wave analysis in hypertension management: current evidence and perspectives. Curr Hypertens Rep 18:72CrossRefPubMed
18.
go back to reference Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024CrossRefPubMed Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024CrossRefPubMed
19.
go back to reference Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
20.
go back to reference Hametner B, Wassertheurer S, Kropf J, Mayer C, Eber B, Weber T (2013) Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements. Blood Press Monit 18:173–176CrossRefPubMed Hametner B, Wassertheurer S, Kropf J, Mayer C, Eber B, Weber T (2013) Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements. Blood Press Monit 18:173–176CrossRefPubMed
21.
go back to reference Weiss W, Gohlisch C, Harsch-Gladisch C, Tolle M, Zidek W, van der Giet M (2012) Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit 17:128–131CrossRefPubMed Weiss W, Gohlisch C, Harsch-Gladisch C, Tolle M, Zidek W, van der Giet M (2012) Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit 17:128–131CrossRefPubMed
22.
go back to reference Feistritzer HJ, Reinstadler SJ, Klug G et al (2015) Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One 10:e0116862CrossRefPubMedPubMedCentral Feistritzer HJ, Reinstadler SJ, Klug G et al (2015) Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One 10:e0116862CrossRefPubMedPubMedCentral
23.
go back to reference Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366CrossRefPubMed Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366CrossRefPubMed
24.
go back to reference Hansen TW, Thijs L, Li Y et al (2010) Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 55:1049–1057CrossRefPubMed Hansen TW, Thijs L, Li Y et al (2010) Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 55:1049–1057CrossRefPubMed
25.
go back to reference Wilkinson IB, Fuchs SA, Jansen IM et al (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084CrossRefPubMed Wilkinson IB, Fuchs SA, Jansen IM et al (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084CrossRefPubMed
26.
go back to reference Franklin SS, O’Brien E, Thijs L, Asayama K, Staessen JA (2015) Masked hypertension: a phenomenon of measurement. Hypertension 65:16–20CrossRefPubMed Franklin SS, O’Brien E, Thijs L, Asayama K, Staessen JA (2015) Masked hypertension: a phenomenon of measurement. Hypertension 65:16–20CrossRefPubMed
27.
go back to reference Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL (2010) Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 87:240–245CrossRefPubMed Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL (2010) Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 87:240–245CrossRefPubMed
28.
go back to reference Mateo-Gavira I, Vilchez-Lopez FJ, Garcia-Palacios MV, Carral-San Laureano F, Jimenez-Carmona S, Aguilar-Diosdado M (2016) Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complicat 30:1326–1332CrossRefPubMed Mateo-Gavira I, Vilchez-Lopez FJ, Garcia-Palacios MV, Carral-San Laureano F, Jimenez-Carmona S, Aguilar-Diosdado M (2016) Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complicat 30:1326–1332CrossRefPubMed
29.
go back to reference Head GA, Mihailidou AS, Duggan KA et al (2010) Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 340:c1104CrossRefPubMedPubMedCentral Head GA, Mihailidou AS, Duggan KA et al (2010) Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 340:c1104CrossRefPubMedPubMedCentral
30.
31.
go back to reference Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71:e13–e115 Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71:e13–e115
32.
go back to reference Drawz PE, Pajewski NM, Bates JT et al (2017) Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension 69:42–50CrossRefPubMed Drawz PE, Pajewski NM, Bates JT et al (2017) Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension 69:42–50CrossRefPubMed
33.
go back to reference Gordin D, Waden J, Forsblom C et al (2012) Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) study. Ann Med 44:196–204CrossRefPubMed Gordin D, Waden J, Forsblom C et al (2012) Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) study. Ann Med 44:196–204CrossRefPubMed
34.
go back to reference Luzardo L, Lujambio I, Sottolano M et al (2012) 24-H ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res 35:980–987CrossRefPubMed Luzardo L, Lujambio I, Sottolano M et al (2012) 24-H ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res 35:980–987CrossRefPubMed
35.
go back to reference Omboni S, Posokhov IN, Parati G et al (2016) Vascular health assessment of the hypertensive patients (VASOTENS) registry: study protocol of an international, web-based telemonitoring registry for ambulatory blood pressure and arterial stiffness. JMIR Res Protoc 5:e137CrossRefPubMedPubMedCentral Omboni S, Posokhov IN, Parati G et al (2016) Vascular health assessment of the hypertensive patients (VASOTENS) registry: study protocol of an international, web-based telemonitoring registry for ambulatory blood pressure and arterial stiffness. JMIR Res Protoc 5:e137CrossRefPubMedPubMedCentral
Metadata
Title
Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes
Authors
Raija Lithovius
Daniel Gordin
Carol Forsblom
Markku Saraheimo
Valma Harjutsalo
Per-Henrik Groop
on behalf of the FinnDiane Study Group
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4648-5

Other articles of this Issue 9/2018

Diabetologia 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine